A conserved MADS-box phosphorylation motif regulates differentiation and mitochondrial function in skeletal, cardiac, and smooth muscle cells

Cell Death and Disease

Volumn 6, Issue 10, 2015, Pages

  Mughal, W ^a   Nguyen, L ^a   Pustylnik, S ^b   Da Silva Rosa, S C ^a   Piotrowski, S ^a   Chapman, D ^a   Du, M ^b   Alli, N S ^b   Grigull, J ^b   Halayko, A J ^a   Aliani, M ^a   Topham, M K ^c   Epand, R M ^d   Hatch, G M ^a   Pereira, T J ^a   Kereliuk, S ^a   McDermott, J C ^b   Rampitsch, C ^e   Dolinsky, V W ^a   Gordon, J W ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b YORK UNIVERSITY   (Canada)

^c UNIVERSITY OF UTAH   (United States)

^d MCMASTER UNIVERSITY   (Canada)

^e AGRICULTURE AND AGRI FOOD CANADA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DIACYLGLYCEROL; INSULIN; MICRORNA; MICRORNA 133A; MYOCYTE ENHANCER FACTOR 2; PALMITIC ACID; PROTEIN; PROTEIN KINASE C DELTA; PROTEIN NIX; SERUM RESPONSE FACTOR; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG; MIRN133 MICRORNA, HUMAN;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIAC MUSCLE CELL; CELL DIFFERENTIATION; CELL FUNCTION; CELL MEMBRANE DEPOLARIZATION; CONTROLLED STUDY; FEMALE; FETUS DEVELOPMENT; GENE MUTATION; GENE SILENCING; HUMAN; HUMAN CELL; IN VIVO STUDY; INSULIN RESISTANCE; LIPID STORAGE; LIPOTOXICITY; MADS BOX PHOSPHORYLATION MOTIF; MASS SPECTROMETRY; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION; MITOPHAGY; NONHUMAN; PEPTIDE MAPPING; POSITION WEIGHT MATRIX; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; RAT; SITE DIRECTED MUTAGENESIS; SKELETAL MUSCLE CELL; SMOOTH MUSCLE CELL; TANDEM MASS SPECTROMETRY; TRANSLATION REGULATION; YOUNG ADULT; ANIMAL; CELL CULTURE; CHEMISTRY; CHLOROCEBUS AETHIOPS; COS 1 CELL LINE; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; PREGNANCY; PRENATAL EXPOSURE;

AMINO ACID MOTIFS; ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; COS CELLS; DIABETES, GESTATIONAL; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MEF2 TRANSCRIPTION FACTORS; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICRORNAS; MITOCHONDRIA; MUSCLE FIBERS, SKELETAL; MUTAGENESIS, SITE-DIRECTED; MYOCYTES, CARDIAC; MYOCYTES, SMOOTH MUSCLE; PHOSPHORYLATION; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RATS; SERUM RESPONSE FACTOR; TANDEM MASS SPECTROMETRY;

EID: 84975293572     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2015.306     Document Type: Article

References (50)

1. Florini JR, Ewton DZ, Magri KA. Hormones, growth factors, and myogenic differentiation. Annu Rev Physiol 1991; 53: 201-216.
2. Harvey RP. Patterning the vertebrate heart. Nat Rev Genet 2002; 3: 544-556.
3. Owens GK, Kumar MS, Wamhoff BR. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev 2004; 84: 767-801.
4. Bayol SA, Simbi BH, Stickland NC. A maternal cafeteria diet during gestation and lactation promotes adiposity and impairs skeletal muscle development and metabolism in rat offspring at weaning. J Physiol 2005; 567: 951-961.
5. Pereira TJ, Fonseca MA, Campbell KE, Moyce BL, Cole LK, Hatch GM et al. Maternal obesity characterized by gestational diabetes increases the susceptibility of rat offspring to hepatic steatosis via a disrupted liver metabolome. J Physiol 2015; 593: 3181-3197.
6. Parker MH, Seale P, Rudnicki MA. Looking back to the embryo: defining transcriptional networks in adult myogenesis. Nat Rev Genet 2003; 4: 497-507.
7. Kelly RG. Molecular inroads into the anterior heart field. Trends Cardiovasc Med 2005; 15: 51-56.
8. Majesky MW. Developmental basis of vascular smooth muscle diversity. Arterioscler Thromb Vasc Biol 2007; 27: 1248-1258.
9. Potthoff MJ, Wu H, Arnold MA, Shelton JM, Backs J, McAnally J et al. Histone deacetylase degradation and MEF2 activation promote the formation of slow-twitch myofibers. J Clin Invest 2007; 117: 2459-2467.
10. Potthoff MJ, Olson EN. MEF2: a central regulator of diverse developmental programs. Development 2007; 134: 4131-4140.
11. Cox DM, Du M, Marback M, Yang ECC, Chan J, Siu KWM et al. Phosphorylation motifs regulating the stability and function of myocyte enhancer factor 2 A. J Biol Chem 2003; 278: 15297-15303.
12. Rampalli S, Li L, Mak E, Ge K, Brand M, Tapscott SJ et al. p38 MAPK signaling regulates recruitment of Ash2L-containing methyltransferase complexes to specific genes during differentiation. Nat Struct Mol Biol 2007; 14: 1150-1156.
13. Du M, Perry RLS, Nowacki NB, Gordon JW, Salma J, Zhao J et al. Protein kinase A represses skeletal myogenesis by targeting myocyte enhancer factor 2D. Mol Cell Biol 2008; 28: 2952-2970.
14. Miano JM. Serum response factor: toggling between disparate programs of gene expression. J Mol Cell Cardiol 2003; 35: 577-593.
15. Miano JM, Ramanan N, Georger MA, de Mesy Bentley KL, Emerson RL, Balza RO et al. Restricted inactivation of serum response factor to the cardiovascular system. Proc Natl Acad Sci USA 2004; 101: 17132-17137.
16. Li S, Czubryt MP, McAnally J, Bassel-Duby R, Richardson JA, Wiebel FF et al. Requirement for serum response factor for skeletal muscle growth and maturation revealed by tissuespecific gene deletion in mice. Proc Natl Acad Sci USA 2005; 102: 1082-1087.
17. Czubryt MP, McAnally J, Fishman GI, Olson EN. Regulation of peroxisome proliferatoractivated receptor gamma coactivator 1 alpha (PGC-1 alpha) and mitochondrial function by MEF2 and HDAC5. Proc Natl Acad Sci USA 2003; 100: 1711-1716.
18. Liu N, Williams AH, Kim Y, McAnally J, Bezprozvannaya S, Sutherland LB et al. An intragenic MEF2-dependent enhancer directs muscle-specific expression of microRNAs 1 and 133. Proc Natl Acad Sci USA 2007; 104: 20844-20849.
19. Liu N, Bezprozvannaya S, Shelton JM, Frisard MI, Hulver MW, McMillan RP et al. Mice lacking microRNA 133a develop dynamin 2-dependent centronuclear myopathy. J Clin Invest 2011; 121: 3258-3268.
20. Torella D, Iaconetti C, Catalucci D, Ellison GM, Leone A, Waring CD et al. MicroRNA-133 controls vascular smooth muscle cell phenotypic switch in vitro and vascular remodeling in vivo. Circ Res 2011; 109: 880-893.
21. Coll T, Jové M, Rodríguez-Calvo R, Eyre E, Palomer X, Sánchez RM et al. Palmitatemediated downregulation of peroxisome proliferator-activated receptor-gamma coactivator 1alpha in skeletal muscle cells involves MEK1/2 and nuclear factor-kappaB activation. Diabetes 2006; 55: 2779-2787.
22. Gordon JW, Dolinsky VW, Mughal W, Gordon GRJ, McGavock J. Targeting skeletal muscle mitochondria to prevent type 2 diabetes in youth. Biochem Cell Biol 2015: 1-14.
23. Gordon JW, Pagiatakis C, Salma J, Du M, Andreucci JJ, Zhao J et al. Protein kinase A-regulated assembly of a MEF2{middle dot}HDAC4 repressor complex controls c-Jun expression in vascular smooth muscle cells. J Biol Chem 2009; 284: 19027-19042.
24. Wheaton K, Riabowol K. Protein kinase C delta blocks immediate-early gene expression in senescent cells by inactivating serum response factor. Mol Cell Biol 2004; 24: 7298-7311.
25. Zhang J, Ney PA. Role of BNIP3 and NIX in cell death, autophagy, and mitophagy. Cell Death Differ 2009; 16: 939-946.
26. Chen S, Puthanveetil P, Feng B, Matkovich SJ, Dorn GW II, Chakrabarti S. Cardiac miR-133a overexpression prevents early cardiac fibrosis in diabetes. J Cell Mol Med 2014; 18: 415-421.
27. Chen J-F, Mandel EM, Thomson JM, Wu Q, Callis TE, Hammond SM et al. The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat Genet 2006; 38: 228-233.
28. Perry RLS, Yang C, Soora N, Salma J, Marback M, Naghibi L et al. Direct interaction between myocyte enhancer factor 2 (MEF2) and protein phosphatase 1alpha represses MEF2-dependent gene expression. Mol Cell Biol 2009; 29: 3355-3366.
29. Shulga YV, Loukov D, Ivanova PT, Milne SB, Myers DS, Hatch GM et al. Diacylglycerol kinase delta promotes lipogenesis. Biochemistry 2013; 52: 7766-7776.
30. Clark RI, Tan SWS, Péan CB, Roostalu U, Vivancos V, Bronda K et al. MEF2 is an in vivo immune-metabolic switch. Cell 2013; 155: 435-447.
31. Chen G, Cizeau J, Vande Velde C, Park JH, Bozek G, Bolton J et al. Nix and Nip3 form a subfamily of pro-apoptotic mitochondrial proteins. J Biol Chem 1999; 274: 7-10.
32. Cheung KG, Cole LK, Xiang B, Chen K, Ma X, Myal Y et al. Sirtuin-3 (SIRT3) protein attenuates doxorubicin-induced oxidative stress and improves mitochondrial respiration in H9c2 cardiomyocytes. J Biol Chem 2015; 290: 10981-10993.
33. Ornatsky OI, Cox DM, Tangirala P, Andreucci JJ, Quinn ZA, Wrana JL et al. Post-translational control of the MEF2A transcriptional regulatory protein. Nucleic Acids Res 1999; 27: 2646-2654.
34. Vega RB, Harrison BC, Meadows E, Roberts CR, Papst PJ, Olson EN et al. Protein kinases C and D mediate agonist-dependent cardiac hypertrophy through nuclear export of histone deacetylase 5. Mol Cell Biol 2004; 24: 8374-8385.
35. Chen Y, Lewis W, Diwan A, EH-Y Cheng, Matkovich SJ, Dorn GW. Dual autonomous mitochondrial cell death pathways are activated by Nix/BNip3L and induce cardiomyopathy. Proc Natl Acad Sci USA 2010; 107: 9035-9042.
36. Schweers RL, Zhang J, Randall MS, Loyd MR, Li W, Dorsey FC et al. NIX is required for programmed mitochondrial clearance during reticulocyte maturation. Proc Natl Acad Sci USA 2007; 104: 19500-19505.
37. Liu N, Bezprozvannaya S, Williams AH, Qi X, Richardson JA, Bassel-Duby R et al. microRNA-133a regulates cardiomyocyte proliferation and suppresses smooth muscle gene expression in the heart. Genes Dev 2008; 22: 3242-3254.
38. Matkovich SJ, Wang W, Tu Y, Eschenbacher WH, Dorn LE, Condorelli G et al. MicroRNA-133a protects against myocardial fibrosis and modulates electrical repolarization without affecting hypertrophy in pressure-overloaded adult hearts. Circ Res 2010; 106: 166-175.
39. Yussman MG, Toyokawa T, Odley A, Lynch RA, Wu G, Colbert MC et al. Mitochondrial death protein Nix is induced in cardiac hypertrophy and triggers apoptotic cardiomyopathy. Nat Med 2002; 8: 725-730.
40. Carè A, Catalucci D, Felicetti F, Bonci D, Addario A, Gallo P et al. MicroRNA-133 controls cardiac hypertrophy. Nat Med 2007; 13: 613-618.
41. Zhang W, Morris QD, Chang R, Shai O, Bakowski MA, Mitsakakis N et al. The functional landscape of mouse gene expression. J Biol 2004; 3: 21.
42. Mcdermott JC, Cardoso MC, Yu YT, Andres V, Leifer D, Krainc D et al. hMEF2C gene encodes skeletal muscle- and brain-specific transcription factors. Mol Cell Biol 1993; 13: 2564-2577.
43. Pagiatakis C, Gordon JW, Ehyai S, Mcdermott JC. A novel RhoA/ROCK-CPI-17-MEF2C signaling pathway regulates vascular smooth muscle cell gene expression. J Biol Chem 2012; 287: 8361-8370.
44. Chiang HR, Schoenfeld LW, Ruby JG, Auyeung VC, Spies N, Baek D et al. Mammalian microRNAs: experimental evaluation of novel and previously annotated genes. Genes Dev 2010; 24: 992-1009.
45. Medjkane S, Perez-Sanchez C, Gaggioli C, Sahai E, Treisman R. Myocardin-related transcription factors and SRF are required for cytoskeletal dynamics and experimental metastasis. Nat Cell Biol 2009; 11: 257-268.
46. Fei P, Wang W, Kim S-H, Wang S, Burns TF, Sax JK et al. Bnip3L is induced by p53 under hypoxia, and its knockdown promotes tumor growth. Cancer Cell 2004; 6: 597-609.
47. Wang NS. Transient expression of wild-type or mitochondrially targeted Bcl-2 induces apoptosis, whereas transient expression of endoplasmic reticulum-targeted Bcl-2 is protective against Bax-induced cell death. J Biol Chem 2001; 276: 44117-44128.
48. Gosens R, Stelmack GL, Dueck G, Mcneill KD, Yamasaki A, Gerthoffer WT et al. Role of caveolin-1 in p42/p44 MAP kinase activation and proliferation of human airway smooth muscle. Am J Physiol Lung Cell Mol Physiol 2006; 291: L523-L534.
49. Chavez JA, Summers SA. Characterizing the effects of saturated fatty acids on insulin signaling and ceramide and diacylglycerol accumulation in 3T3-L1 adipocytes and C2C12 myotubes. Arch Biochem Biophys 2003; 419: 101-109.
50. Dolinsky VW, Rueda-Clausen CF, Morton JS, Davidge ST, Dyck JRB. Continued postnatal administration of resveratrol prevents diet-induced metabolic syndrome in rat offspring born growth restricted. Diabetes 2011; 60: 2274-2284.